Dieterich E, Baier W K, Doose H, Tuxhorn I, Fichsel H
Neuropediatrics. 1985 Aug;16(3):149-54. doi: 10.1055/s-2008-1052560.
The purpose of the follow-up study was to determine whether modern therapy with ethosuximide and/or valproate with/without phenobarbitone and its derivatives improves the longterm prognosis of absence epilepsy as compared to formerly used treatments. The patient population consisted of 194 cases (88 boys, 106 girls) with spike wave epilepsy starting with absences. In each case the diagnosis was confirmed by clinical observation and the typical EEG pattern. Only those patients were included who could be followed beyond the eighteenth year of life (up to age 45). The sample includes also older patients diagnosed during the fifties, before the present standard therapy was available. Because of the heterogeneity of the material and its selection, the data obtained are not suited to make a general statement about the ultimate prognosis of absences. The results demonstrate the effectiveness of regularly applied modern treatment. 72 out of 194 patients (37%) manifested generalized tonic clonic seizures (gtcs) during the course: 20 of these patients showed only incidental generalized tonic clonic seizures, which were not dependent on therapy. In 52 cases gtcs appeared without relation to precipitating factors. None of these patients received regular standard therapy before onset of gtcs. In 31 cases absence statuses were observed. These patients did not have an unfavourable outcome provided the standard therapy was instituted early and consequently. A change from absence epilepsy into an epilepsy with complex partial seizures sensu strictiori could not be observed. At final investigation 42 of 194 patients still had seizures: 7 with absences, 35 with grand mal with or without absences.(ABSTRACT TRUNCATED AT 250 WORDS)
这项随访研究的目的是确定与以前使用的治疗方法相比,使用乙琥胺和/或丙戊酸盐联合/不联合苯巴比妥及其衍生物的现代疗法是否能改善失神癫痫的长期预后。患者群体包括194例(88名男孩,106名女孩)以失神发作起病的棘波癫痫患者。每例患者均通过临床观察和典型的脑电图模式确诊。仅纳入那些能够随访至18岁以后(直至45岁)的患者。该样本还包括50年代确诊的老年患者,当时尚无目前的标准疗法。由于材料的异质性及其选择方式,所获得的数据不适合对失神的最终预后做出一般性陈述。结果表明了定期应用现代治疗的有效性。194例患者中有72例(37%)在病程中出现了全身强直阵挛发作(GTCS):其中20例患者仅出现偶发的全身强直阵挛发作,与治疗无关。52例患者的GTCS发作与诱发因素无关。这些患者在GTCS发作前均未接受正规的标准治疗。观察到31例失神持续状态。如果早期并持续进行标准治疗,这些患者的预后并不差。未观察到失神癫痫转变为严格意义上的复杂部分性发作癫痫。在最终调查时,194例患者中有42例仍有发作:7例为失神发作,35例为大发作,伴或不伴失神发作。(摘要截取自250字)